No connection

Search Results

AMS vs SILO

AMS
American Shared Hospital Services
BEARISH
Price
$1.33
Market Cap
$8.8M
Sector
Healthcare
AI Confidence
95%
SILO
Silo Pharma, Inc.
BEARISH
Price
$0.52
Market Cap
$8.4M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
AMS
--
SILO
--
Forward P/E
AMS
3.34
SILO
-0.74
P/B Ratio
AMS
0.37
SILO
1.09
P/S Ratio
AMS
0.31
SILO
116.19
EV/EBITDA
AMS
8.29
SILO
-0.1

Profitability

Gross Margin
AMS
38.31%
SILO
38.57%
Operating Margin
AMS
-13.98%
SILO
-4363.27%
Profit Margin
AMS
-5.53%
SILO
0.0%
ROE
AMS
-9.45%
SILO
-74.56%
ROA
AMS
-2.18%
SILO
-35.63%

Growth

Revenue Growth
AMS
-14.8%
SILO
0.0%
Earnings Growth
AMS
--
SILO
--

Financial Health

Debt/Equity
AMS
0.78
SILO
--
Current Ratio
AMS
0.76
SILO
11.36
Quick Ratio
AMS
0.71
SILO
10.55

Dividends

Dividend Yield
AMS
--
SILO
--
Payout Ratio
AMS
0.0%
SILO
0.0%

AI Verdict

AMS BEARISH

AMS exhibits severe financial distress, anchored by a weak Piotroski F-Score of 2/9 and a critical liquidity position with a current ratio of 0.76. The company is experiencing a systemic decline, evidenced by a -14.80% YoY revenue contraction and a disastrous -200% YoY EPS growth. Despite a low Price-to-Book ratio of 0.37, the stock is in a technical freefall (0/100 trend) and consistently misses earnings estimates by wide margins. The combination of negative profitability and shrinking top-line growth suggests a value trap rather than a value opportunity.

Strengths
Positive Gross Margin (38.31%)
Low Price-to-Book ratio (0.37)
Low Price-to-Sales ratio (0.31)
Risks
Severe liquidity risk (Current Ratio 0.76 < 1.0)
Negative revenue growth (-14.80% YoY)
Consistent and massive earnings misses (Recent surprise -550%)
SILO BEARISH

SILO exhibits critical financial distress, highlighted by a Piotroski F-Score of 0/9, indicating a total lack of fundamental improvement across all measured categories. The company is currently pre-revenue or stagnant (0% YoY growth) with an unsustainable operating margin of -4363.27%. While a high current ratio of 11.36 suggests a temporary cash runway, the long-term trajectory is severely negative with a 5-year price decline of 96%. The recent 1-month price spike appears to be speculative volatility rather than a fundamental turnaround.

Strengths
Strong short-term liquidity (Current Ratio: 11.36)
Price/Book ratio near 1.09 suggests the stock is trading close to its accounting value
Recent short-term price momentum (+60.9% in 1 month)
Risks
Extreme fundamental weakness (Piotroski F-Score 0/9)
Zero revenue growth (YoY and Q/Q)
Massive operating losses (-4363.27% operating margin)

Compare Another Pair

AMS vs SILO: Head-to-Head Comparison

This page compares American Shared Hospital Services (AMS) and Silo Pharma, Inc. (SILO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile